ADX NEUROSCIENCES
ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. ADx was founded in 2011 by 4 pioneers in biomarker development and Alzheimer’s disease research. They combine more than 45 years of knowledge and experience and presents an impressive track record developing superior, highly... performant and unique diagnostic biomarkers. The ADx markers allow accurate diagnosis even before symptoms appear, provide valuable patient information and bridge the gap between disease and novel treatments. Both in vitro diagnostic companies as well as pharma companies benefit from the ADx technology. IVD companies utilize the ADx biomarkers and antibodies on various automated platforms and test kits. In search of novel therapies, pharmaceutical companies rely on the ADx assays and services to accelerate and improve the design of large clinical trials.
ADX NEUROSCIENCES
Social Links:
Industry:
Biotechnology Neuroscience
Founded:
2011-01-01
Address:
Gent, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.adxneurosciences.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Clinical Genomics Technologies
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Employees Featured
Founder
Official Site Inspections
http://www.adxneurosciences.com
- Host name: 188.208.37.108.static.hosted.by.combell-ops.net
- IP address: 188.208.37.108
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
More informations about "ADx NeuroSciences"
About Us – ADx Neurosciences – State-of-the-art …
A close and personal relationship with our extensive academic network ensures access to the latest innovations; We apply these biomarkers and antibodies to …See details»
ADx Neurosciences – State-of-the-art biomarker assays
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease …See details»
ADx NeuroSciences - Crunchbase Company Profile & Funding
ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions.See details»
ADx NeuroSciences - LinkedIn
ADx NeuroSciences | 1,932 followers on LinkedIn. ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases …See details»
ADx NeuroSciences 2025 Company Profile: Valuation, …
ADx NeuroSciences General Information Description. Developer of biomarker assays intended to detect neurodegenerative diseases. The company offers …See details»
ADx NeuroSciences Company Profile | Gent, Belgium | Competitors ...
Find company research, competitor information, contact details & financial data for ADx NeuroSciences of Gent. Get the latest business insights from Dun & Bradstreet.See details»
ADx NeuroSciences - Products, Competitors, Financials, Employees ...
ADx NeuroSciences. Frequently Asked Questions (FAQ). When was ADx NeuroSciences founded? ADx NeuroSciences was founded in 2011. Where is ADx NeuroSciences's …See details»
ADx NeuroSciences - VentureRadar
"Adx focuses on the identification of biomarkers and the development of assays to be used in the diagnosis of dementia, as well as the treatment and follow-up of patients with …See details»
ADx NeuroSciences - Ownership and Business Overview - Mergr
Jun 23, 2022 Belgium, www.adxneurosciences.com. Profile Investors (1) Analytics ADx NeuroSciences is an R&D-driven company specializing in the development of …See details»
State-of-the-art biomarker assays - ADx Neurosciences
ADx NeuroSciences was founded in 2011 by pioneers in biomarker development and Alzheimer’s disease research. We combine more than 45 years of knowledge and experience, and have built an impressive track record developing …See details»
ADx NeuroSciences - Overview, News & Similar companies
Jun 23, 2022 www.adxneurosciences.com. Revenue $7.1 Million. Industry Business Services General Business Services . Recent News & Media. Neuroscience Antibodies & Assays …See details»
ADx NeuroSciences NV - CMOCRO - Domain Name
ADx NeuroSciences NV is a Belgium-based biotech company. The company focuses on the identification of novel biomarkers and the development of assays for these markers to be used …See details»
ADx NeuroSciences - 2025 Company Profile - Tracxn
Feb 22, 2025 What are the most recent funding rounds of ADx NeuroSciences? Its latest funding round was a Grant (prize money) round on Nov 01, 2019 for $588K. 1 investor participated in …See details»
State-of-the-art biomarker assays - ADx Neurosciences
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
Fujirebio acquires ADx NeuroSciences and confirms its intentions …
Jun 23, 2022 “By welcoming ADx NeuroSciences in the Fujirebio group of companies, Fujirebio will be able to expand its antibody supply business and contract development and …See details»
ADx NeuroSciences - Craft
ADx NeuroSciences is a company that provides biomarker assays for neurodegenerative diseases. It develops antibodies and assays to quantify biomarkers in conditions such as …See details»
ADx NeuroSciences and Alamar Biosciences announce partnership …
October 28, 2024 – Gent, Belgium and Fremont, CA, USA – ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, …See details»
ADx NeuroSciences | flanders.bio
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease …See details»
Fujirebio acquires ADx NeuroSciences and confirms its intentions …
Jun 23, 2022 Gent, Belgium and Tokyo, Japan, June 23, 2022 – H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and ADx NeuroSciences NV today …See details»
State-of-the-art biomarker assays - ADx Neurosciences
”Too often our internally developed biomarkers hit the wall when we want to use them in clinical trials. We therefore rely on biomarker development expertise at ADx to develop robust and …See details»